EBAG9 | Estrogen receptor binding site associated, antigen, 9 | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
EEF2 | Eukaryotic translation elongation factor 2 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EFNB2 | Ephrin-B2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EIF4H | Eukaryotic translation initiation factor 4H | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EIF5A | Eukaryotic translation initiation factor 5A | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENO1 | Enolase 1, (alpha) | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ERCC1 | Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERCC3 | Excision repair cross-complementing rodent repair deficiency, complementation group 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ETHE1 | Ethylmalonic encephalopathy 1 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ETV4 | Ets variant 4 | Cancer-related genes Transcription factors
| | | | | Mixed |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
F3 | Coagulation factor III (thromboplastin, tissue factor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
FADD | Fas (TNFRSF6)-associated via death domain | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FAM129A | Family with sequence similarity 129, member A | Cancer-related genes
| | | | | Expressed in all |
FAS | Fas cell surface death receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FEN1 | Flap structure-specific endonuclease 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
FKBP8 | FK506 binding protein 8, 38kDa | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
FOS | FBJ murine osteosarcoma viral oncogene homolog | Cancer-related genes Transcription factors
| | | | | Expressed in all |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FOXO1 | Forkhead box O1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOXO3 | Forkhead box O3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FSCN1 | Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FZD1 | Frizzled family receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GCLM | Glutamate-cysteine ligase, modifier subunit | Cancer-related genes
| | | | | Expressed in all |